Test for statin side effects launched

June 1, 2012
Some people stop taking statins because of fears over side effects. Credit: iStockphoto/Marcelo Wain

(Medical Xpress) -- A simple diagnostic test developed at Oxford University, and launched today by Massachusetts-based Boston Heart Diagnostics, will identify those at increased risk of rare but serious side effects from taking cholesterol-lowering statin drugs.

Isis Innovation, the University's technology commercialisation company, granted Boston Heart Diagnostics an exclusive US license to the test in 2011. The test is now available for license in non-US territories, including the UK.

Researchers at Oxford University's Clinical Trial Service Unit, led by Professor Rory Collins, identified the genetic biomarker SLCO1B1, which is an effective identifier of patients at increased risk of myopathy – the onset of muscle aches, pains and weakness associated with statin therapy. This condition can be extremely unpleasant and occasionally becomes very serious.

"Lowering cholesterol with statin therapy results in a substantial reduction in heart attacks, stroke and cardiovascular mortality and larger reductions in produce larger benefits," said Professor Collins. "In rare cases, myopathy occurs in association with statin therapy, especially when the statins are given at higher doses and with certain other medications. Knowledge of the SLCO1B1 marker may help to achieve the benefits of statin therapy more safely and effectively."

Boston Heart Diagnostics has now launched the Statin Induced Myopathy (SLCO1B1) Genotype test. The test classifies individuals into high risk or low risk genotypes based on the presence or absence of the SLCO1B1 .

"Of course there are any number of reasons that people ignore their healthcare provider's advice, but statin-induced myopathy can be extremely unpleasant and, for a small percentage, completely debilitating – leading many to forego taking the potentially life-saving drug," said Boston Heart Diagnostics President and CEO Susan Hertzberg.

"We are delighted to assist in bringing this important new test to the US market through an exclusive arrangement with Boston Diagnostics," said Tom Hockaday, Managing Director of Isis Innovation. "The test has the potential to allow physicians worldwide to assist patients to choose the best and safest treatment option for their particular case.'

Explore further: Statins prevent cancer in heart transplant recipients

Related Stories

Statins prevent cancer in heart transplant recipients

May 20, 2012
Statins prevent cancer and reduce death from all causes in heart transplant recipients. The findings were independent of cholesterol levels.

Intensive-dose statin therapy associated with increased risk of diabetes

June 21, 2011
An analysis of data from previously published studies indicates that intensive-dose statin therapy is associated with an increased risk of new-onset diabetes compared with moderate-dose therapy, according to a study in the ...

Recommended for you

Hibernating ground squirrels provide clues to new stroke treatments

November 17, 2017
In the fight against brain damage caused by stroke, researchers have turned to an unlikely source of inspiration: hibernating ground squirrels.

Age and gut bacteria contribute to multiple sclerosis disease progression

November 17, 2017
Researchers at Rutgers Robert Wood Johnson Medical School published a study suggesting that gut bacteria at young age can contribute to multiple sclerosis (MS) disease onset and progression.

Molecular guardian defends cells, organs against excess cholesterol

November 16, 2017
A team of researchers at the Harvard T. H. Chan School of Public Health has illuminated a critical player in cholesterol metabolism that acts as a molecular guardian in cells to help maintain cholesterol levels within a safe, ...

Prototype ear plug sensor could improve monitoring of vital signs

November 16, 2017
Scientists have developed a sensor that fits in the ear, with the aim of monitoring the heart, brain and lungs functions for health and fitness.

Ancient enzyme could boost power of liquid biopsies to detect and profile cancers

November 16, 2017
Scientists are developing a set of medical tests called liquid biopsies that can rapidly detect the presence of cancers, infectious diseases and other conditions from only a small blood sample. Researchers at The University ...

FDA to crack down on risky stem cell offerings

November 16, 2017
U.S. health authorities announced plans Thursday to crack down on doctors pushing stem cell procedures that pose the gravest risks to patients amid an effort to police a burgeoning medical field that previously has received ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

PeterD
not rated yet Jun 05, 2012
Only an idiot would take statins since there is no evidence that shows that these drugs help you live longer. they are a complete fraud!

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.